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PURPOSE. To compare cone spacing and choriocapillaris (CC) perfusion adjacent to geographic
atrophy (GA) in patients with age-related macular degeneration (AMD) and age-similar normal
eyes.
METHODS. Subjects were imaged using adaptive optics scanning laser ophthalmoscopy
(AOSLO), fundus autofluorescence (FAF), and swept-source optical coherence tomography
angiography. The GA border was identified using FAF images; CC flow void was analyzed in 18
regions extending from the GA border. A grader masked to CC perfusion selected regions of
interest (ROIs) with unambiguous cone mosaics in AOSLO images. At each ROI, cone spacing
and CC flow void were converted to Z-scores (standard deviations from the mean of 12
normal eyes aged 50 to 81 years for cone spacing, and 60 normal eyes age 51 to 88 years for
CC flow void).
RESULTS. Excluding regions of GA and drusen, CC flow void in eight eyes of six patients with
AMD was significantly greater than in four age-similar normal eyes (exact permutation test, P
¼ 0.024). CC flow void was negatively correlated with distance from the GA margin (r ¼
0.35; 95% confidence interval [CI], 0.53 to 0.12). Increased cone spacing was
significantly correlated with CC flow void (r ¼ 0.33; 95% CI, 0.12 to 0.59). Cone spacing
was increased in 39% of ROIs, while CC flow void was increased in 96% of ROIs.
CONCLUSIONS. In eyes with GA due to AMD, CC hypoperfusion was significantly correlated
with, and more extensive than, cone photoreceptor loss. The results suggest that reduced CC
perfusion contributes to the development of GA.
Keywords: adaptive optics scanning laser ophthalmoscopy, geographic atrophy, swept source
optical coherence tomography angiography
Age-related macular degeneration (AMD) is the leading causeof visual loss in elderly Americans.1 Vision loss develops in
patients who develop choroidal neovascularization and in
patients with geographic atrophy (GA), when the atrophy
involves fixation. GA occurs less commonly than choroidal
neovascularization in AMD, but there are no effective treat-
ments for GA, and eyes that develop GA have slightly lower
visual acuity scores than those that develop neovasculariza-
tion.2 GA in AMD is characterized by loss of outer retinal cells in
the macular region. Understanding the initial cause of GA may
facilitate the development of clinical therapeutic strategies for
the prevention of GA and subsequent vision loss in AMD. GA
causes atrophy of the photoreceptors, retinal pigment epithe-
lium (RPE), and choriocapillaris (CC), but it remains unclear
whether the primary lesion involves cellular (RPE/photorecep-
tor) or vascular (CC) loss. Most attempts to develop therapies
to prevent GA have focused on photoreceptor and RPE loss.3,4
Phase 2 and 3 clinical trials targeted to RPE and photoreceptor
preservation are ongoing (National Clinical Trial numbers
02659098, 03446144, 02686658, 02286089, 01782989,
02564978, 02684578, 02087085, and 02463344). However,
an alternative theory posits that blood flow abnormalities play
an important role in AMD based on deficiencies of choroidal
blood flow in early and late AMD.5,6 Histologic studies have
identified reduced CC density at the edge of GA lesions in AMD
patients,7 and impaired CC perfusion may lead to impaired RPE
function, degradation of photoreceptors, decreased antioxidant
capacity, and increased drusen deposition.7 CC loss is visible in
early and intermediate stage AMD in histologic sections and is
more advanced with increased AMD severity, suggesting that
early CC loss could be a useful biomarker of the development
and progression of GA.7
Understanding the cause of GA has been limited by the
inability to obtain in vivo high-resolution images of photore-
ceptors, RPE, and CC perfusion in patients with AMD.
Additionally, standard clinical imaging modalities, such as
fluorescein and indocyanine green (ICG) angiography, fundus
autofluorescence (FAF), and cross-sectional optical coherence
tomography (OCT) B-scans lack the resolution necessary to
characterize the earliest alterations in CC, photoreceptors, and
RPE cells. Newer noninvasive imaging techniques for assessing
CC perfusion and photoreceptors with cellular-level resolution
in vivo may improve understanding of how GA develops. OCT-
based angiography (OCTA) permits noninvasive, functional
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imaging of retinal and choroidal vasculature8–10 and has been
used to visualize alterations in the CC of patients with dry
AMD.8 Swept-source OCT angiography (SS-OCTA), which
features a high acquisition speed and an improved penetration
depth, is a promising technology to provide insight into CC
changes in GA.8,11 Adaptive optics scanning laser ophthalmos-
copy (AOSLO) enables direct visualization of waveguiding cone
photoreceptors with cellular-level resolution, which permits
quantitative measurements of changes in cone spacing or the
average distance between neighboring cones.12–14 Adaptive
optics measure and compensate for aberrations in the optical
path between the imaging camera and the retina.12 AOSLO has
been used to image retinal structures in AMD.13,15,16 The
combination of AOSLO and OCTA has the resolution to
visualize macular photoreceptors and underlying CC perfusion
in patients. We used these noninvasive, high-resolution retinal
imaging techniques to compare cone photoreceptors and CC
perfusion in regions bordering GA due to nonneovascular AMD
with similar locations in normal eyes.
MATERIALS AND METHODS
This study was approved by the Institutional Review Board of
University of California, San Francisco, and informed consent
was obtained from all subjects before performing study
procedures. The study followed the tenets of the Declaration
of Helsinki and was conducted in compliance with the Health
Insurance Portability and Accountability Act. The clinical
characteristics of the subjects studied are provided in the
Table. All participants received comprehensive examinations
of the anterior and posterior segments. Patients with AMD
were considered for enrollment according to the following
inclusion criteria: visual acuity >20/40, dry AMD with drusen
>125-lm diameter, GA sparing the fovea, and no evidence of
choroidal neovascularization or exudation in the study eye.
The normal eyes were from age-similar subjects with visual
acuity >20/40 in each eye and no AMD. All eyes studied had
less than six diopters myopia and no other retinal vascular
disease. Visual acuity was measured according to the Early
Treatment of Diabetic Retinopathy Study (ETDRS) protocol
with a measurement and correction of refractive error.17
Imaging studies included color fundus photos (TRC 50DX;
Topcon Medical Systems, Inc., Oakland, NJ, USA), axial length
A scan measurements (IOL Master; Carl Zeiss Meditec, Dublin,
CA, USA), cross-sectional spectral-domain OCT (SD-OCT)
images including high resolution 208 horizontal and vertical
B-scans, and 2083158 volume scans and FAF images (Spectralis
HRAþOCT; Heidelberg Engineering, Vista, CA, USA). Regions
of GA were outlined from areas of reduced autofluorescence in
FAF images. Regions of increased backscatter with increased
reflectance in infrared fundus images and SD-OCT images were
used to confirm ambiguous areas of reduced autofluorescence
in FAF images.
The custom-built AOSLO system used a low-coherence light
source (NKT-EXR15; NKT Photonics, Inc., Denmark) with a
central wavelength of 840 nm, a Shack-Hartmann wavefront
sensor, and a 140-actuator microelectromechanical deformable
mirror (Boston Micromachines Corporation, Watertown, MA,
USA) as described previously.13 The AOSLO montage covered
areas of GA, adjacent borders of GA lesions, and CC normal-
appearing regions for each subject.
An SS-OCTA system (PLEX Elite 9000; Carl Zeiss Meditec
Inc.) was used for angiographic image acquisition, with a
central wavelength of 1,060 nm and a speed of 100,000 A-scans
per second. The axial and lateral resolutions of the system
were ~5 lm in tissue and ~14 lm at the retinal surface. The
scan pattern used in this study was 6 mm3 6 mm field of view,
incorporating 500 B-scan positions in the slow axis, with each
B-scan comprised of 500 A-scans (fast axis). At each B-scan
position, the scanning was repeated twice to enable blood
flow extraction by using the optical microangiography
(OMAG) algorithm.18 The scanning depth was 3 mm over
1536 pixels. A semiautomated segmentation algorithm was
used to accurately identify the RPE/Bruch’s membrane (BM)
complex layer from the structural OCT volume derived from
the OCTA dataset.19 A slab starting from the outer boundary of
BM to approximately 20 lm beneath BM was used to define the
CC slab, upon which an algorithm was used to quantify the CC
flow void, as previously described.20 Briefly, this quantification
algorithm first used the CC structural information to compen-
sate for shadowing caused by the RPE and BM on the CC flow
map, and then projection artifacts due to overlying retinal
blood flow were removed using a previously described
algorithm.21 Finally, the percentage of CC with abnormally
low flow (flow voids [FVs] or flow deficits) was calculated
based on a thresholding strategy that defines abnormal CC flow
at each pixel as one standard deviation below the mean flow
signals obtained from a normative database of 20 young normal
subjects with normal CC perfusion (aged from 20 to 39 years
old).20 One standard deviation was selected for FV identifica-
tion because it has been validated to be reproducible and
repeatable.20 FV in each normal eye was compared at the same
bands used to define regions extending from the margins of GA
for each of the eight patient eyes, and the %FV values were
averaged for each band in each normal eye to compare normal
CC FV at the same locations as were measured in patients by
using an exact permutation test. Lastly, a comparison of FV
with cone spacing was performed using regions extending in
18 concentric bands centered on the foveal avascular zone in
normal eyes. Within regions of GA, outlined based on FAF
images, CC hypoperfusion was present, and large choroidal
vessels were visible. Drusen were identified using an automat-
ed algorithm to segment a layer from the RPE to BM on the
structural en face SS-OCT images.20 Regions occupied by
drusen and GA were excluded from calculations of CC flow
void.20
Color fundus and FAF images were superimposed with
vertical and horizontal SD-OCT B-scans, AOSLO montage
images, and OCTA images by using retinal vascular landmarks.
Regions near the edge of GA without drusen visible on OCT,
color fundus photography, or FAF fundus images were selected
for further analysis. Five regions extending in 18 bands from the
GA borders were identified, in which quantitative CC flow void
percentages were analyzed in patients with GA. To compare
with the normal subjects, the five bands identified above were
precisely overlaid onto the normal CC maps by using the
central fovea as the reference. In this way, the CC flow void
percentage evaluated from the concentric regions identified in
GA subjects were compared with the spatial location-similar
regions from the normal subject (Fig. 1B) and compared by
using an exact permutation test (see below). An examiner (AR)
masked to CC perfusion status selected 50 lm350 lm regions
of interest (ROIs) in which unambiguous cone mosaics were
visible in the AOSLO montages. Cone spacing was measured
using custom software (Matlab, Natick, MA, USA) to derive a
density recovery profile histogram,22 as described previously.23
Cone spacing varies with eccentricity from the fovea, so cone
spacing values were converted to Z-scores, or number of
standard deviations from the mean, based on a normative
database of cone spacing measures in 12 normal eyes aged 50
to 81 years.13 CC FVs were also converted to Z-scores based on
a normative database of 60 eyes aged 51 to 89 years (mean, 69
years; standard deviation, 10 years). The Z-score is calculated as
Zi ¼ FVDiFVDSD , where Z is Z-score, FVD and SD are the mean
and standard deviation of flow void density (percentage; FVD)
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from normal database, respectively, and i indicates each eye. A
lower Z-score means lower CC FVD, and a negative Z-score
means FVDs below mean FVD of normal database. Normal Z-
scores were between2 and 2. Two standard deviations were
used to evaluate how the FVD in the eye deviates from an age-
similar normal population, as two is the standard threshold that
has been commonly used to determine normal range.
STATISTICAL ANALYSIS
A permutation test was used to compare the difference of
means in CC FVs between AMD patients and normal subjects.
Spearman’s rank correlation was used to compare cone
spacing and CC flow void Z-scores at ROIs corresponding to
regions with color-coded CC FVs at the margins of GA in AMD
patients and in normal eyes at similar eccentricities. A
bootstrap analysis, clustered by patient to account for the fact
that one eye was used in some subjects and both eyes were
used in others, was used to derive 95% CI values. Statistical
significance was defined as P < 0.05 or 95% CI ranges that did
not include zero.
RESULTS
Clinical and imaging data were collected from eight eyes of six
patients with GA and no evidence of neovascularization, and
from two eyes of two age-similar normal subjects. Refractive
error ranged from þ3.50 to 1.50 spherical equivalents.
The vascular perfusion of the CC slabs in age-similar normal
subjects showed a mean CC flow void of 12.53% 6 1.68% with
a Z-score of 0.20 An example of CC FVs in 18 bands extending
from the fovea is shown in an age-similar normal subject and a
patient with GA (Fig. 1). An assessment of concentric 18 bands
surrounding the GA margin showed that CC flow void values
were significantly greater than in normal eyes for all regions
examined in all patients (exact permutation test, difference of
means between AMD patients and normal subjects, P¼ 0.024).
CC FVs were not significantly correlated with GA area
(Spearman’s rank correlation r ¼ 0.47; 95% CI, 0.94 to
0.80), but CC flow void was negatively correlated with
eccentricity from the GA margin (Spearman’s rank correlation
r¼0.35; 95% CI, 0.53 to 0.12) in AMD patients.
Figure 2 shows representative images of two eyes with GA
acquired from multiple imaging modalities, incorporating color
TABLE. Clinical Characteristics of Subjects Studied







Patient 1 (P1) Right 40120 83 M Late AMD (GA) 20/25 83
Patient 1 (P1) Left 40120 83 M Late AMD (GA) 20/25 85
Patient 2 (P2) Left 40118 75 F Late AMD (GA) 20/32 78
Patient 3 (P3) Left 40117 82 M Late AMD (GA) 20/25 80
Patient 4 (P4) Right 40124 84 M Late AMD (GA) 20/30-2 78
Patient 5 (P5) Right 40128 70 F Late AMD (GA) 20/25 83
Patient 5 (P5) Left 40128 70 F Late AMD (GA) 20/25 83
Patient 6 (P6) Right 40129 78 M Late AMD (GA) 20/20 84
Normal 1 (N1) Left 10021 79 M No AMD 20/12 95
Normal 2 (N2) Right 40119 57 M No AMD 20/20 88
Normal 3 (N3) Right 40171 81 F No AMD 20/20 85
Normal 3 (N3) Left 40171 81 F No AMD 20/20 87
Y, years; M, male; F, female.
* AMD Classification is based on the Clinical Classification System for AMD, which is proposed by the Macular Research Classification
Committee.24 ETDRS, early treatment of diabetic retinopathy study.17
FIGURE 1. Representative color fundus and OCTA images of normal
subject N2, 40019R (A, B) and patient P5, 40128R (C, D). Color fundus
photo of N2 (A) shows several patches of RPE depigmentation but no
drusen were present on OCT B-scans, while P5 (C) shows drusen, areas
of GA, and focal RPE hyperplasia. Color photos were scaled to match
the 6 mm3 6 mm OCTA images in (B) and (D). FVs within five color
coded regions that extend in 18 concentric bands from the margin of
GA are overlaid onto the CC OCTA maps obtained from (B) normal and
(D) GA subjects: 1st band, 08 to 18 (red); 2nd band, 18 to 28 (magenta);
3rd band, 28 to 38 (yellow); 4th band, 38 to 48 (blue); and outside,
greater than 48 (green). GA regions are outlined in black. Colored
pixels in (B) and (D) indicate regions of the CC flow void, defined as
greater than 1 standard deviation below the mean of 20 normal
subjects aged 20 to 39 years.20 (E) CC flow void percentage across the
bands and Z-scores for each of the 5 bands. Red asterisks show the
foveal center; scale bar: 1 mm.
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fundus photos (Figs. 2A, 2E), FAF (Figs. 2B, 2F), and SD-OCT B-
scans (Figs. 2C–H). The regions imaged with SS-OCTA (white
dashed outline) and AOSLO (white solid outline) images were
precisely superimposed and marked for comparisons between
the cone mosaic and CC perfusion. GA areas appeared as
sharply delineated regions of RPE loss in FAF fundus photos
(Figs. 2B, 2F), whereas OCT B-scans show increased backscat-
ter (Figs. 2C–H), which were marked by graders as black
outlines as shown. The eyes shown in Figure 2 showed the
lowest CC flow void percentages of all subjects studied and
may represent the least abnormal example. Images of the other
six eyes are shown in the supplementary Figures 1 through 3.
Figure 3 shows the representative OCTA CC images with
AMD and AOSLO images with ROIs where cone spacing was
measured. FVs were labeled with color-coded pixels overlaid
with OCTA CC images (Figs. 3A, 3D). AOSLO images were
precisely superimposed with OCTA CC images, with ROIs
extending 50 lm 3 50 lm (Figs. 3B, 3E). FVD and Z-scores
were calculated for regions extending from the GA margin in
concentric 18 color-coded bands, labelled 1st through 4th8,
with outside representing the region greater than 48 from the
GA margin (Figs. 3C, 3F). Results of the other six eyes are
shown in Supplementary Figures S4 through S6.
Figure 4 shows representative cone spacing measurements
at ROIs superimposed on the color-coded concentric 18 bands,
shown as 5 bands extending from the GA margin. Cone
spacing and CC flow void percentages in each 18 concentric
band were calculated as Z-scores and compared with age-
similar normal values.
Figure 5 shows cone spacing with respect to eccentricity
for the ROIs in three age-similar normal eyes and all eight eyes
with AMD. The majority (28/46, or 61%) of cone spacing values
in eyes with GA fell within the 95% CIs around the normal
mean and showed cone spacing Z-scores <2. However, 18/46,
or 39%, of ROIs showed cone spacing values that were
increased by greater than the 95% CIs, with cone spacing Z-
scores >2. Cone spacing Z-scores were significantly and
positively correlated with CC flow void Z-scores (Spearman’s
rank correlation rho ¼ 0.33; 95% CI, 0.12 to 0.59). CC
perfusion was abnormally reduced, with a CC flow void Z-
score >2 in 44 of the 46 ROIs where cone spacing was
measured in the eyes with AMD (Fig. 5, red squares). Only 2 of
the 46 (4%) ROIs were located in regions with normal CC
perfusion (CC flow void Z-score, <2), and in both of these
ROIs, cone spacing fell within normal limits (Fig. 5, blue
squares).
DISCUSSION
Reduced CC perfusion, represented by increased CC flow void,
was correlated with increased cone photoreceptor spacing in
eyes with nonneovascular AMD and fovea-sparing GA, suggest-
ing that CC hypoperfusion accompanies cone loss. CC flow
void was significantly correlated with increased cone spacing;
there were regions with normal cone spacing in areas with
reduced CC perfusion, but no regions with increased cone
spacing in locations with normal CC perfusion (Fig. 5).
Furthermore, CC flow void was significantly and negatively
correlated with distance from the edge of GA. The data suggest
that CC hypoperfusion was observed more commonly and
more extensively than the loss of overlying cone photorecep-
tors and that CC hypoperfusion may precede RPE atrophy, GA
enlargement, and cone photoreceptor loss. However, it is
possible that cones have normal spacing but may have
decreased function with reduced metabolic demand, resulting
in reduced CC flow. Rods, which were not imaged in the
current study, are lost and have impaired function in eyes with
AMD,25,26 and it is possible that rod loss may cause reduced CC
flow despite normal cone spacing measures. Longitudinal
studies of patients with AMD are necessary to establish the
relationship between photoreceptor loss, CC flow void, and
GA progression.
The CC flow void was significantly greater in the regions
surrounding the margin of GA in the AMD patients than in
normal eyes. This is similar to histologic studies that have
shown CC loss even in early stages of AMD,7 and OCTA may
provide a sensitive method to measure the earliest CC
perfusion changes in eyes with AMD. CC flow void throughout
the 6 mm 3 6 mm region showed diffuse CC flow
abnormalities in eyes with GA due to AMD. In the current
study, GA area was not significantly correlated with CC flow
void, but this small study may have been insufficiently powered
to detect a significant relationship between GA area and CC
flow void.
The combination of AOSLO and OCTA imaging may shed
new light on the mechanism of GA progression. GA area was
defined by hypoautofluorescence by using FAF images as a
surrogate for RPE cell survival, but RPE cells were not
evaluated with resolution commensurate with the resolution
of the AOSLO and OCTA systems used to study cone
photoreceptors and CC perfusion, respectively. Images in the
current manuscript were acquired using a confocal AOSLO
system, in which white spots in a mosaic represent cones with
FIGURE 2. Representative multimodal images of GA in 2 eyes (P1, OU)
with AMD. (A, E) Color fundus images of eyes with GA; white solid
lines depict the area for AOSLO montage imaging. (B, F) FAF images;
black outlines depict GA margins, and white solid outlines depict the
area for AOSLO imaging. (C, G) FAF, near infrared, and SD-OCT. (B)
Scan images were superimposed precisely; green lines, location of
horizontal and vertical OCT cross-sectional B-scans; white dotted lines
indicate the area for OCTA imaging. (D, H) Corresponding vertical OCT
cross-sectional B-scans in C, G. Similar images are shown for patients P2
to P6 in Supplementary Figures S1 through S3. Scale bars: 200 lm.
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intact inner and outer segments in contact with RPE cells.27
Nonconfocal AOSLO systems can provide a high-quality
visualization of cones that have inner segments but without
intact outer segments,28 and RPE cells can be imaged using
split detection and dark field AOSLO systems.29 Confocal
images of RPE cells have been demonstrated using short-
wavelength autofluorescence,30–32 near-infrared autofluores-
cence,15 two-photo autofluorescence in nonhuman primates,33
and adaptive optics enhanced ICG.34 Combined with confocal
AOSLO imaging systems, nonconfocal AOSLO is capable of
FIGURE 3. Representative OCTA CC images in 2 eyes (P1, OU: OD, top row; and OS, bottom row) with AMD. The CC FVs are shown as colored
pixels in regions extending from the GA margin in concentric 18 color-coded bands, labeled 1st to 4th8, with outside representing the region greater
than 48 from the GA margin (black outlines), and AOSLO images with ROIs where cone spacing was measured. GA area and drusen were excluded
from the CC flow void analysis. (A, D) CC images with color-coded FVs. (B, E) AOSLO images with ROIs extending 50 lm3 50 lm labeled with
letters and numbers indicating relative position with respect to the fovea. UL, upper left; UR, upper right; LL, lower left; LR, lower right; N, nasal; T,
temporal; S, superior; P, patient. Scale bars: 500 lm. (C, F) GA area, CC FVD, and Z-scores for each of the 5 regions extending from the GA margin as
follows: 1st, 08 to 18 (red); 2nd, 18 to 28 (magenta); 3rd, 28 to 38 (yellow); 4th, 38 to 48 (blue); outside, greater than 48 (green) from the GA margin.
Images from patients P2 OS and P3 OS are shown in Supplementary Figure S4, P4 OD and P5 OD in Supplementary Figure S5, and P5 OS and P6 OD
are shown in Supplementary Figure S6.
FIGURE 4. Representative AOSLO montages (outlined in white) superimposed on CC slab from OCTA images. (A) Normal subject N1 (10021L); (B)
patient P1 (40120R) with GA. Green squares (50 lm350 lm) in A show ROIs where cones were unambiguously seen and counted. Green crosses
in enlarged insets (UR1, LL2, and LL5) in the bottom of A show examples of cone selections. In B, the square insets (50 lm3 50 lm) are color
coded with each of the five concentric regions extending from the GA margin as follows: 1st, 08 to 18 (red); 2nd, 18 to 28 (magenta); 3rd, 28 to 38
(yellow); 4th, 38 to 48 (blue); outside, greater than 48 from the GA margin (green). (B) CC FVs are shown for each band. UL, upper left; UR, upper
right; LL, lower left; LR, lower right. UL1, UL2, and UL3 are enlarged at bottom to show cone markings; UR1 versus UL1, LL2 versus UL2, and LL5
versus UL3 were selected for comparison of ROIs at similar eccentricities. Scale bars: 500 lm (large montages) and 50 lm (magnified insets). Images
of P1 OS, P2 OS, P3 OS, P4 OD, P5 OD, P5 OS, and P6 OD with representative ROIs are shown in Supplementary Figure S7.
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providing insight into the progression of photoreceptor and
RPE loss and may be useful for monitoring the effects of
treatments designed to control or slow the progression of
retinal and choroidal diseases. Future studies combining
confocal and nonconfocal AOSLO with OCTA images may
provide further insight into cellular mechanisms of disease
progression in eyes with AMD by demonstrating individual RPE
cells. These studies might also expedite the development and
assessment of therapies to prolong photoreceptor and CC
survival. In addition, future research will study patients
longitudinally to monitor eyes for GA progression. A more
complete understanding of microvascular dynamics and
changes in cone photoreceptors may enhance our understand-
ing of the pathophysiology of GA in AMD patients.
Most current clinical trials to treat GA have been directed at
photoreceptor3 or RPE4 degeneration or inflammatory mech-
anisms mediated through the alternate complement pathway.35
Although several studies have investigated CC perfusion in
eyes with GA due to AMD,5,6,36 the advent of OCTA makes it
much easier to investigate the relationship between CC
perfusion and GA progression. If longitudinal studies demon-
strate a correlation between CC FVs and increased risk of GA
progression, therapies to address impaired blood supply to the
outer retina in patients with AMD may reduce the risk of GA
progression and vision loss. Here, we have demonstrated that
CC alterations correlate with cone photoreceptor abnormali-
ties, as CC FVs were associated with increased cone spacing.
These findings suggest that impaired CC perfusion may
contribute to GA development and photoreceptor loss. Future
prospective, longitudinal studies of CC perfusion and cone
survival in eyes with AMD and GA may demonstrate whether
CC perfusion abnormalities precede or predict future cone loss
and GA progression.
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